Patent · US Active

Tropoelastin-based protoelastin biomaterials

US7700126B2 · kind B2 · utility

14Cited by
3References
22Claims
0Family size

Inventors

Key dates

Filing dateSep 28, 2007
Grant dateApr 20, 2010
Priority date
Expiry dateSep 28, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L31/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Biocompatible materials suitable for use in vascular applications have been engineered, combining human recombinant tropoelastin with other synthetic or natural biomaterials to form protoelastin. The materials can be in the form of elastin films on metal, bone, ceramic or polymer substrates, laminates of alternating polymer and elastin, blends of polymer and elastin, or elastin crosslinked with or tethered to polymer. The flexibility in engineering and design makes protoelastin biomaterials suited not only to the production of conduits but any number of other vascular applications that require blood contacting surfaces. Tropoelastin and the subsequently engineered biomaterial protoelastin provide the opportunity to satisfy a large unmet need for a biocompatible material adaptable enough to meet a range of diverse vascular uses. These are mechanically stable, elastic, strong and biocompatible (i.e., not thrombogenic and promoting adhesion of cells, especially human endothelial cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.